CDCamille Draguet

Camille Draguet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Camille Draguet has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric threshold

    by Camille Draguet, Pieter Populaire, Macarena Chocan Vera, Karin Haustermans, John A. Lee, Ana M. Barragán-Montero, Edmond Sterpin


  • Anticipating potential bottlenecks in adaptive proton FLASH therapy: a ridge filter reuse strategy

    by Benjamin Roberfroid, Macarena S Chocan Vera, Camille Draguet, John A Lee, Ana M Barragán-Montero, Edmond Sterpin

    Objective. Achieving FLASH dose rate with pencil beam scanning intensity modulated proton therapy is challenging. However, utilizing a single energy layer with a ridge filter (RF) can maintain dose rate and conformality. Yet, changes in patient anatomy over the treatment course can render the RF obsolete. Unfortunately, creating a new RF is time-consuming, thus, incompatible with online adaptation. To address this, we propose to re-optimize the spot weights while keeping the same initial RF. Approach. Data from six head and neck cancer patients with a repeated computed tomography (CT2) were used. FLASH treatment plans were generated with three methods on CT2: ‘full-adaptation’ (FA), optimized from scratch with a new RF; ‘spot-adaptation only’ (SAO), re-using initial RF but adjusting plan spot weights; and ‘no adaptation’ (NoA) where the dose from initial plans on initial CT (CT1) was recomputed on CT2. The prescribed dose per fraction was 9 Gy. Different beam angles were tested for each CT2 (1 beam per fraction). The FA, SAO and NoA plans were then compared on CT2. Main results. Fractions with SAO showed a median decrease of 0.05 Gy for D98% and a median increase of 0.03 Gy for D2% of CTV when compared to their homologous FA plans on nominal case. Median conformity number decreased by 0.03. Median max dose to spinal cord increased by 0.09 Gy. The largest median increase in mean dose to organs was 0.03 Gy to the mandible. The largest observed median difference in organs receiving a minimal dose rate of 40 Gy s−1 was 0.5% for the mandible. Up to 16 of the 20 evaluated SAO fractions were thus deemed clinically acceptable, with up to 8 NoA plans already acceptable before adaptation. Significance. Proposed SAO workflow showed that for most of our evaluated plans, daily reprinting of RF was not necessary.


  • Open Access

    Potential of automated online adaptive proton therapy to reduce margins for oesophageal cancer

    by Pascal Herbst, Camille Draguet, Ana M. Barragán-Montero, Elena Borderías Villarroel, Macarena Chocan Vera, Pieter Populaire, Karin Haustermans, Edmond Sterpin


  • A comparative study on automatic treatment planning for online adaptive proton therapy of esophageal cancer: which combination of deformable registration and deep learning planning tools performs the best?

    by C Draguet, P Populaire, M Chocan Vera, A Fredriksson, K Haustermans, J A Lee, A M Barragán-Montero, E Sterpin

    Objective. To demonstrate the feasibility of integrating fully-automated online adaptive proton therapy strategies (OAPT) within a commercially available treatment planning system and underscore what limits their clinical implementation. These strategies leverage existing deformable image registration (DIR) algorithms and state-of-the-art deep learning (DL) networks for organ segmentation and proton dose prediction. Approach. Four OAPT strategies featuring automatic segmentation and robust optimization were evaluated on a cohort of 17 patients, each undergoing a repeat CT scan. (1) DEF-INIT combines deformably registered contours with template-based optimization. (2) DL-INIT, (3) DL-DEF, and (4) DL-DL employ a nnU-Net DL network for organ segmentation and a controlling ROIs-guided DIR algorithm for internal clinical target volume (iCTV) segmentation. DL-INIT uses this segmentation alongside template-based optimization, DL-DEF integrates it with a dose-mimicking (DM) step using a reference deformed dose, and DL-DL merges it with DM on a reference DL-predicted dose. All strategies were evaluated on manual contours and contours used for optimization and compared with manually adapted plans. Key dose volume metrics like iCTV D98% are reported. Main results. iCTV D98% was comparable in manually adapted plans and for all strategies in nominal cases but dropped to 20 Gy in worst-case scenarios for a few patients per strategy, highlighting the need to correct segmentation errors in the target volume. Evaluations on optimization contours showed minimal relative error, with some outliers, particularly in template-based strategies (DEF-INIT and DL-INIT). DL-DEF achieves a good trade-off between speed and dosimetric quality, showing a passing rate (iCTV D98% > 94%) of 90% when evaluated against 2, 4 and 5 mm setup error and of 88% when evaluated against 7 mm setup error. While template-based methods are more rigid, DL-DEF and DL-DL have potential for further enhancements with proper DM algorithm tuning. Significance. Among investigated strategies, DL-DEF and DL-DL demonstrated promising within 10 min OAPT implementation results and significant potential for improvements.


  • Automated clinical decision support system with deep learning dose prediction and NTCP models to evaluate treatment complications in patients with esophageal cancer

    by Camille Draguet, Ana M. Barragán-Montero, Macarena Chocan Vera, Melissa Thomas, Pieter Populaire, Gilles Defraene, Karin Haustermans, John A. Lee, Edmond Sterpin


  • Open Access

    Towards a safe and efficient clinical implementation of machine learning in radiation oncology by exploring model interpretability, explainability and data-model dependency

    by Ana Barragán-Montero, Adrien Bibal, Margerie Huet Dastarac, Camille Draguet, Gilmer Valdés, Dan Nguyen, Siri Willems, Liesbeth Vandewinckele, Mats Holmström, Fredrik Löfman, et al.

    The interest in machine learning (ML) has grown tremendously in recent years, partly due to the performance leap that occurred with new techniques of deep learning, convolutional neural networks for images, increased computational power, and wider availability of large datasets. Most fields of medicine follow that popular trend and, notably, radiation oncology is one of those that are at the forefront, with already a long tradition in using digital images and fully computerized workflows. ML models are driven by data, and in contrast with many statistical or physical models, they can be very large and complex, with countless generic parameters. This inevitably raises two questions, namely, the tight dependence between the models and the datasets that feed them, and the interpretability of the models, which scales with its complexity. Any problems in the data used to train the model will be later reflected in their performance. This, together with the low interpretability of ML models, makes their implementation into the clinical workflow particularly difficult. Building tools for risk assessment and quality assurance of ML models must involve then two main points: interpretability and data-model dependency. After a joint introduction of both radiation oncology and ML, this paper reviews the main risks and current solutions when applying the latter to workflows in the former. Risks associated with data and models, as well as their interaction, are detailed. Next, the core concepts of interpretability, explainability, and data-model dependency are formally defined and illustrated with examples. Afterwards, a broad discussion goes through key applications of ML in workflows of radiation oncology as well as vendors’ perspectives for the clinical implementation of ML.